4//SEC Filing
RXBAZAAR INC 4
Accession 0001072613-02-001458
CIK 0001115295operating
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 5:11 PM ET
Size
12.4 KB
Accession
0001072613-02-001458
Insider Transaction Report
Form 4
No transactions or holdings reported in this filing.
Footnotes (5)
- [1]Currently, there is no active trading market for the common stock. RxBazaar expects that its common stock will be listed for quotation on the OTC Bulletin Board under a symbol to be assigned by the National Association of Securities Dealers, Inc.
- [2]Received pursuant to a stock dividend paid on RxBazaar's outstanding Series A Preferred Stock.
- [3]Able has entered into an agreement with RxBazaar under which it may not convert or exercise any derivative security of RxBazaar if immediately after such conversion or exercise it would beneficially own greater than 4.9% of the issued and outstanding shares of common stock of RxBazaar.
- [4]Each share of Series A Preferred Stock is convertible into one share of common stock.
- [5]Estimated. Able has the right to convert the notes at the then current market price of the common stock. Able Laboratories, Inc. /s/ Dhananjay G. Wadekar, President & CEO September 11, 2002 - --------------------------------------------- ----------------------- **
Documents
Issuer
RXBAZAAR INC
CIK 0001115295
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001115295
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 5:11 PM ET
- Size
- 12.4 KB